Topic Review
Therapeutic Potential of MSC-EVs in Neurodegenerative Disorders
The application of mesenchymal stem cells (MSCs) represents a new promising approach for treating neurodegenerative diseases. Growing evidence suggests that the therapeutic effects of MSCs are due to the secretion of neurotrophic molecules through extracellular vesicles. The extracellular vesicles produced by MSCs (MSC-EVs) have valuable innate properties deriving from parental cells and could be exploited as cell-free treatments for many neurological diseases.
  • 527
  • 23 Feb 2023
Topic Review
Therapeutic Potential of Apoptotic MSCs or MSC-Derived ApoBDs
Mesenchymal stem cells (MSCs) have shown promising therapeutic effects both in preclinical studies (in animal models of a wide range of diseases) and in clinical trials. However, the efficacy of MSC-based therapy is not always predictable. Moreover, despite the large number of studies, the mechanisms underlying the regenerative potential of MSCs are not fully elucidated. It has been reliably established that transplanted MSCs can undergo rapid apoptosis and clearance from the recipient’s body, still exhibiting therapeutic effects, especially those associated with their immunosuppressive/immunomodulating properties. The mechanisms underlying these effects can be mediated by the efferocytosis of apoptotic MSCs by host phagocytic cells.
  • 382
  • 18 Nov 2022
Topic Review
Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that arises in the exocrine glands of the pancreas and comprises over 90% of pancreatic malignancies. Currently the 11th most common cancer worldwide, PDAC is the seventh leading cause of cancer-related deaths and is on track to move to second place by 2030. Despite the high prevalence, therapeutic options remain limited, with only modest improvements in overall survival (OS) occurring over the past 50 years.
  • 492
  • 12 Oct 2021
Topic Review
Therapeutic Approaches of Radioresistance in NSCLC
Survival in unresectable locally advanced stage non-small cell lung cancer (NSCLC) patients remains poor despite chemoradiotherapy. Adjuvant immunotherapy improved survival for these patients but it is still far from curing most of the patients with only a 57% survival remaining at 3 years. This poor survival is due to the resistance to chemoradiotherapy, local relapses, and distant relapses. Several biological mechanisms have been found to be involved in the chemoradioresistance such as cancer stem cells, cancer mutation status, or the immune system. New drugs to overcome this radioresistance in NSCLCs have been investigated such as radiosensitizer treatments or immunotherapies. Different modalities of radiotherapy have also been investigated to improve efficacity such as dose escalation or proton irradiations.
  • 311
  • 24 Jun 2022
Topic Review
The Oligodendrocytes in Brain Ischemia-Reperfusion Injury
Oligodendrocytes are the responsible cells for axon myelination in the central nervous system. Oligodendrocytes are especially sensitive to oxidative stress and excitotoxicity generated during brain ischemia.
  • 457
  • 27 Jun 2022
Topic Review
The Ubiquitin Proteasome System and Mitochondrial Homeostasis
Mitochondria abundance and activity are fundamental elements underlying the dynamic adaptation of cells to stress conditions. The shape and number of mitochondria are tightly controlled by key biological processes, such as fusion and fission (also known as mitochondrial dynamics) and mitophagy that operate in an interconnected and dynamic way to sustain cellular health and metabolic needs.
  • 350
  • 13 Jan 2023
Topic Review
The Tubulin Code in Mitosis
Mitosis relies on the critical contribution of microtubules, as well as several microtubule-associated proteins (MAPs) and motors, to regulate several key mechanisms underlying the faithful segregation of the genetic material during cell division. The mitotic spindle is an anisotropic and highly heterogeneous structure, with dynamic astral microtubules essentially tyrosinated, in contrast with more stable microtubule subpopulations, such as kinetochore and a fraction of interpolar microtubules, which accumulate detyrosinated, Δ2, acetylated and polyglutamylated tubulin.
  • 841
  • 06 Jan 2023
Topic Review
The Sumoylation Pathway
Post-translational modifications (PTMs) are key regulators of most biological processes. Besides phosphorylation, methylation, acetylation and others, covalent modification of proteins by small polypeptides of the ubiquitin-like modifiers (UBLs) family have gained importance. Among UBLs, the small ubiquitin-like modifier (SUMO), of ~90 amino acids and discovered in the nineties, has proven to regulate most cellular processes. The sumoylation pathway is quite similar to the ubiquitination pathway, but there is its own set of enzymes for modification by SUMO.
  • 1.0K
  • 25 Jul 2022
Topic Review
The Sarcoplasmic Reticulum of Skeletal Muscle Cells
The sarcoplasmic reticulum (SR) is a specialized form of the endoplasmic reticulum of muscle cells, dedicated to calcium ion (Ca2+) handling, necessary for muscle contraction and relaxation.
  • 592
  • 31 Mar 2022
Topic Review
The RUNX Family Promote Genomic Instability
The RUNX family of transcription factors, including RUNX1, RUNX2, and RUNX3, are key regulators of development and can function as either tumor suppressors or oncogenes in cancer. Emerging evidence suggests that the dysregulation of RUNX genes can promote genomic instability in both leukemia and solid cancers by impairing DNA repair mechanisms. RUNX proteins control the cellular response to DNA damage by regulating the p53, Fanconi anemia, and oxidative stress repair pathways through transcriptional or non-transcriptional mechanisms. 
  • 379
  • 04 May 2023
  • Page
  • of
  • 161
Video Production Service